Drug intelligence / Profile preview

1-phenylcyclohexylamine

Development stage
Unknown
Modality
Small Molecules
01

Overview

**1-Phenylcyclohexylamine** is a synthetic aralkylamine compound with the molecular formula C12H17N and a molecular weight of approximately 175.27 g/mol[2][6]. It is structurally related to phencyclidine (PCP), differing by the replacement of PCP’s piperidine ring with a primary amino group[5]. This compound acts as an analog and precursor in the synthesis of PCP[4]. Pharmacologically, it has been shown to possess anticonvulsant activity in animal models, particularly effective in blocking maximal electroshock seizures and antagonizing NMDA-induced behavioral effects at higher doses[5]. Its mechanism involves noncompetitive antagonism at ionotropic glutamate receptors (notably NMDA receptor-coupled channels)[5]. It is classified as an experimental and illicit substance, not approved for medical use, and is listed as a DEA Schedule II controlled substance due to its high potential for abuse and dependence[2][1].

Other names
Cyclohexanamine, 1-phenyl-1-phenylcyclohexan-1-amine2201-24-3
02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)

Beyond the preview

Go deeper on 1-phenylcyclohexylamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 1-phenylcyclohexylamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call